With your own knowledge and the help of the following document:

Document 1 (Title: Immunological Function of Major Histocompatibility Complex): Major histocompatibility complex (MHC) molecules represent critical components of adaptive immunity with distinctive structural and functional characteristics determining their roles in immune recognition processes. Class II histocompatibility molecules demonstrate specific cellular expression patterns predominantly on professional antigen-presenting cells including dendritic cells, macrophages, and B lymphocytes. This restricted distribution pattern contrasts with the nearly ubiquitous expression of class I molecules encoded by HLA-A, B, and C loci. Structural analysis reveals class II molecules comprise non-covalently associated alpha and beta chains, both encoded within the MHC genetic region, rather than incorporating the non-MHC-encoded beta-2-microglobulin component characteristic of class I structures. This heterodimeric architecture creates a distinctive peptide-binding groove accommodating longer peptide fragments compared to class I molecules. Functional studies demonstrate critical roles in exogenous antigen presentation, with class II molecules primarily binding peptides derived from endocytosed and proteolytically processed extracellular proteins. The resulting MHC-peptide complexes interact specifically with T-cell receptors on CD4-positive helper T cells, with the CD4 molecule serving as a co-receptor through direct interaction with class II molecules rather than as their primary ligand. This interaction architecture enables specific recognition of extracellular pathogens and subsequent orchestration of appropriate immune responses through cytokine production and B-cell help. Genetic polymorphism within class II loci contributes to variable disease susceptibility patterns and transplantation compatibility, highlighting their fundamental importance in immunological function and clinical outcomes spanning infectious disease, autoimmunity, and transplantation medicine.
Document 2 (Title: Structural and Functional Aspects of Immunoglobulin Classes): Immunoglobulin D (IgD) represents a distinct antibody class with unique structural characteristics and biological functions within the adaptive immune system. Comparative analysis with other immunoglobulin classes reveals several distinguishing features influencing its physiological roles. Unlike IgE, which plays central roles in immediate hypersensitivity reactions through mast cell and basophil binding leading to mediator release in anaphylactic processes, IgD demonstrates minimal involvement in classical hypersensitivity reactions. Structural analysis through protein crystallography and electron microscopy reveals that IgD heavy chains contain four constant domains (CH1, CH2, CH3, and CH4) rather than the five-domain structure observed in certain other immunoglobulin classes, maintaining the standard antibody architectural pattern with variable regions determining antigen specificity. In contrast to predominantly pentameric IgM and dimeric IgA, IgD exists primarily in monomeric form with the characteristic four-chain structure comprising two heavy and two light chains linked through disulfide bonds. Cellular expression patterns demonstrate that IgD serves predominantly as a membrane-bound antigen receptor on mature B lymphocytes, where it functions alongside IgM as part of the B-cell receptor complex involved in antigen recognition and cellular activation rather than functioning primarily as a secreted antibody. This membrane localization distinguishes it from predominantly secreted immunoglobulins like IgG. Molecular weight analysis through ultracentrifugation and gel filtration chromatography confirms that IgD possesses a molecular mass ranging between approximately 160-190 kDa, placing it in an intermediate position between lighter antibody classes like IgG and heavier structures like pentameric IgM. These distinctive characteristics inform understanding of IgD's specialized roles in B-cell biology and adaptive immune regulation.
Document 3 (Title: Post-translational Regulation of Protein Homeostasis): Protein degradation represents a crucial regulatory mechanism for maintaining cellular homeostasis, controlling quality of protein folding, and regulating the abundance of regulatory proteins. The ubiquitin-proteasome system (UPS) constitutes the principal non-lysosomal proteolytic pathway in eukaryotic cells, responsible for the selective degradation of approximately 80-90% of cellular proteins. The process involves sequential attachment of multiple ubiquitin molecules to target proteins, marking them for recognition and degradation by the 26S proteasome complex. Ubiquitination proceeds through a three-enzyme cascade involving E1 (ubiquitin-activating), E2 (ubiquitin-conjugating), and E3 (ubiquitin ligase) enzymes, culminating in the formation of an isopeptide bond between the C-terminal glycine of ubiquitin and lysine residues on the target protein. Subsequent ubiquitin molecules attach to lysine residues within the previously conjugated ubiquitin, forming polyubiquitin chains with distinct linkage patterns that determine the fate of the tagged protein. Commonly, K48-linked polyubiquitin chains signal proteasomal degradation, while K63-linked chains often mediate non-proteolytic signaling functions. The 26S proteasome represents a large, barrel-shaped multi-catalytic complex comprising a 20S core particle containing proteolytic sites and a 19S regulatory particle responsible for substrate recognition, deubiquitination, unfolding, and translocation. This cylindrical architecture sequesters proteolytic activity within an internal chamber, preventing indiscriminate protein degradation. Upon recognition of polyubiquitinated substrates, the proteasome removes the ubiquitin tags (which are recycled), unfolds the protein substrate through ATP-dependent processes, and progressively degrades it into short peptides and individual amino acids. Dysregulation of this system has been implicated in various pathological states, including neurodegenerative diseases, cancer, and inflammatory disorders, highlighting its fundamental importance in cellular physiology.

Answer the following list question.
Question: Select the correct statement(s): Class II histocompatibility molecules:
Options:
1. Are encoded by genes present at the HLA-A, -B and -C loci
2. Are expressed on B lymphocytes and monocyte macrophages
3. Are formed by an alpha chain associated with beta-2 microglobulin
4. Have CD4 molecule as a ligand
5. Are involved in antigen presentation

Respond strictly in valid JSON format as shown below:
{"answer": ["1", "3"]} ‚Üê if options 1 and 3 are correct
Only output the JSON object. Do not include explanations, labels, markdown, or any other text.